Tourmaline Bio Inc (NASDAQ: TRML) established initial surge of 2.12% at $15.41, before settling in for the price of $15.09 at the close. Taking a more long-term approach, TRML posted a 52-week range of $9.18-$48.31.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 0.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -19.23%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 67.59%. This publicly-traded company’s shares outstanding now amounts to $20.34 million, simultaneously with a float of $15.46 million. The organization now has a market capitalization sitting at $395.27 million. At the time of writing, stock’s 50-day Moving Average stood at $30.77, while the 200-day Moving Average is $27.25.
Tourmaline Bio Inc (TRML) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Tourmaline Bio Inc industry. Tourmaline Bio Inc’s current insider ownership accounts for 39.73%, in contrast to 36.23% institutional ownership. According to the most recent insider trade that took place on Jan 29 ’24, this organization’s Director bought 100,000 shares at the rate of 32.50, making the entire transaction reach 3,250,000 in total value, affecting insider ownership by 448,431. Preceding that transaction, on Nov 17 ’23, Company’s CEO bought 4,000 for 16.99, making the whole transaction’s value amount to 67,960. This particular insider is now the holder of 729,735 in total.
Tourmaline Bio Inc (TRML) Earnings and Revenue Records
Tourmaline Bio Inc’s EPS increase for this current 12-month fiscal period is 67.59% and is forecasted to reach -3.02 in the upcoming year.
Tourmaline Bio Inc (NASDAQ: TRML) Trading Performance Indicators
Let’s observe the current performance indicators for Tourmaline Bio Inc (TRML). It’s Quick Ratio in the last reported quarter now stands at 41.76. The Stock has managed to achieve an average true range (ATR) of 2.00.
In the same vein, TRML’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -11.33, a figure that is expected to reach -0.67 in the next quarter, and analysts are predicting that it will be -3.02 at the market close of one year from today.
Technical Analysis of Tourmaline Bio Inc (TRML)
Now, what If we examine the latest scores posted by [Tourmaline Bio Inc, TRML]. During the last 5-days, its volume was better the volume of 0.39 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 4.33% While, its Average True Range was 1.62.
Raw Stochastic average of Tourmaline Bio Inc (TRML) in the period of the previous 100 days is set at 1.35%, which indicates a major fall in contrast to 5.14% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 70.75% that was lower than 110.46% volatility it exhibited in the past 100-days period.
